MK-8150: Clinical Trials

2 trials of MK-8150, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow MK-8150: new trials by email Literature Review of MK-8150 trials Research Report on MK-8150

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)
MK-8150, Placebo for MK-8150 - Hypertension, Isolated Systolic Hypertension
Phase 1CompletedMerck Sharp & Dohme LLC1032012-08-012018-09-25
A Single Rising Dose Study of MK-8150 (MK-8150-001)
MK-8150 2.0 mg, MK-8150 10 mg, MK-8150 40 mg - Hypertension, Isolated Systolic Hypertension (ISH)
Phase 1CompletedMerck Sharp & Dohme LLC342012-05-072018-09-25

Conditions studied

Hypertension (2)  ·  Isolated Systolic Hypertension (2)

Sponsors

Merck Sharp & Dohme LLC (2)

Results publications

PMID 27561272